However, VEGF-treated animals displayed significantly increased signal intensities within both more proximal (±1.5–1.8 mm distance from stroke core) (right: +28.41 ± 51.96%, p = 0.533, left: +68.81 ± 36.19%, p = 0.031) and distal peri-infarct regions (±1.8–2.1 mm distance from stroke core) (right: +303.46 ± 30.34%, p = 0.001; left: +126.40 ± 33.25%, p = 0.014) compared to Ctrl Ab treated animals. The gene discussed is VEGFA; the disease is Stroke.